Margaill I, Parmentier S, Callebert J, Allix M, Boulu R G, Plotkine M
Laboratoire de Pharmacologie, Université René Descartes, Paris, France.
J Cereb Blood Flow Metab. 1996 Jan;16(1):107-13. doi: 10.1097/00004647-199601000-00013.
The present study investigates the role of N-methyl-D-aspartate (NMDA) receptors in a model of transient focal cerebral ischemia in normotensive rats. The left middle cerebral artery and both common carotid arteries were occluded for 60 min. Preliminary studies indicated that this gave reproducible infarctions of the cortex and striatum. These infarctions were the result of severe ischemia followed by complete reperfusion after clamp removal, as showed by striatal tissue Po2 monitoring. Microdialysis indicated that glutamate concentration increased immediately after occlusion and returned to the baseline value 40 min after clamp removal. MK-801 (1 mg kg-1 i.v.), an antagonist of the NMDA glutamatergic receptor, reduced the cortical infarct volume by 29% (p < 0.001) and the striatal infarct volume by 14% (p < 0.05) when given just prior to ischemia, but had no neuroprotective activity when given 30 min after the onset of ischemia. This short therapeutic window for MK-801 suggests that NMDA receptors play only a transient role in reversible focal ischemia in rats.
本研究在正常血压大鼠的短暂性局灶性脑缺血模型中探究了N-甲基-D-天冬氨酸(NMDA)受体的作用。左侧大脑中动脉和双侧颈总动脉被阻断60分钟。初步研究表明,这会导致可重复性的皮质和纹状体梗死。如纹状体组织氧分压监测所示,这些梗死是严重缺血后在移除血管夹后完全再灌注的结果。微透析表明,闭塞后谷氨酸浓度立即升高,并在移除血管夹后40分钟恢复到基线值。NMDA谷氨酸能受体拮抗剂MK-801(1毫克/千克静脉注射)在缺血前给药时,可使皮质梗死体积减少29%(p<0.001),使纹状体梗死体积减少14%(p<0.05),但在缺血发作30分钟后给药则无神经保护活性。MK-801的这一短暂治疗窗表明,NMDA受体在大鼠可逆性局灶性缺血中仅起短暂作用。